Prognostic and Predictive Biomarkers

While prognostic biomarkers hint at the likely outcome of a patient with a particular disease regardless of their treatment, predictive biomarkers provide information on whether that patient will respond to a certain agent. Some markers provide both of these functions. For instance, estrogen receptor positivity in breast cancer patients indicates a favorable prognosis (providing prognostic information); at the same time, it means that the patient will probably respond to endocrine therapy.

 

  • Prognostic Biomarkers: Analysis of Mutations and Polymorphisms
  • Prognostic Biomarkers: Analysis of Gene and MicroRNA
  • Predictive Biomarkers: Analysis of Mutations and Polymorphisms
  • Predictive Biomarkers: Analysis of Gene and MicroRNA

Related Conference of Prognostic and Predictive Biomarkers

July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE

Prognostic and Predictive Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in